Abstract
Atopic dermatitis is a chronic, pruritic inflammatory dermatosis that affects up to 25% of children and 2% to 3% of adults. This guideline addresses important clinical questions that arise in atopic dermatitis management and care, providing recommendations based on the available evidence. In this third of 4 sections, treatment of atopic dermatitis with phototherapy and systemic immunomodulators, antimicrobials, and antihistamines is reviewed, including indications for use and the risk-benefit profile of each treatment option.
Original language | English (US) |
---|---|
Pages (from-to) | 327-349 |
Number of pages | 23 |
Journal | Journal of the American Academy of Dermatology |
Volume | 71 |
Issue number | 2 |
DOIs | |
State | Published - Aug 2014 |
Funding
Dr Tom is supported by a National Institutes of Health (NIH)/National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) research career development grant ( K23AR060274 ). The content is solely the responsibility of the authors and does not necessarily represent the official views of NIAMS or NIH.
Keywords
- atopic dermatitis
- azathioprine
- cyclosporin A
- interferon gamma
- methotrexate
- mycophenolate mofetil
- oral antihistamines
- oral antimicrobials
- oral steroids
- photochemotherapy
- phototherapy
- systemic therapy
ASJC Scopus subject areas
- Dermatology